Opposing Regulation of the Tight Junction Protein Claudin-2 by Interferon-γ and Interleukin-4

Journal of Surgical Research

Volumn 144, Issue 1, 2008, Pages 1-7

  Wisner, Douglas M ^a   Harris III, Leonard R ^a   Green, Cecelia L ^a   Poritz, Lisa S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

claudin 2; claudin 4; inflammatory bowel disease; interferon gamma (IFN ); interleukin 4 (IL 4); permeability; tight junction; transepithelial resistance

Indexed keywords

CLAUDIN 2; GAMMA INTERFERON; INTERLEUKIN 4;

ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INCUBATION TIME; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; ELECTRIC IMPEDANCE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERFERON TYPE II; INTERLEUKIN-4; INTESTINAL MUCOSA; MEMBRANE PROTEINS; PERMEABILITY; TIGHT JUNCTIONS;

EID: 36849042673     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.03.059     Document Type: Article

References (38)

1. Schneeberger E.E., and Lynch R.D. The tight junction: A multifactorial complex. Am J Physiol Cell Physiol 286 (2004) C1213
2. Furuse M., Fujita K., Hiragi T., et al. Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141 (1998) 1539
3. Poritz L.S., Lynch C.J., Tilberg A.F., et al. Decreased expression of occludin in the intestine of patients with inflammatory bowel disease. FASEB J 11 (1997) A310
4. Koltun W.A., Tillberg A.F., Page M.J., et al. Bowel permeability is improved in Crohn's disease after ileocolectomy. Dis Colon Rectum 41 (1998) 687
5. Schmitz H., Barmeyer C., Fromm M., et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116 (1999) 301
6. Gassler N., Rohr C., Schneider A., et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiolol Gastrointest Liver Physiol 281 (2001) G216
7. Prasad S., Mingrino R., Kaukinen K., et al. Inflammatory processes have differential effects on claudins 2, 3, and 4 in colonic epithelial cells. Lab Invest 85 (2005) 1139
8. Zeissig S., Burgel N., Gunzel D., et al. Changes in expression and distribution of claudin-2, -5, and -8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 56 (2007) 61
9. Poritz L.S., Garver K., Tilberg A.F., et al. Tumor necrosis factor α disrupts tight junction assembly. J Surg Res 116 (2004) 14
10. Youakim A., and Ahdieh M. Interferon-γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 276 (1999) G1279
11. Di Leo V., Yang P.C., Berin M.C., et al. Factors regulating the effect of IL- 4 on intestinal epithelial barrier function. Int Arch Allergy Immunol 129 (2002) 219
12. Colgan S.P., Resnick M.B., Parkos C.A., et al. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 153 (1994) 2122-2129
13. Yoo J., Nochols A., Song J.C., et al. Bryostatin-1 attenuates TNF-induced epithelial barrier dysfunction: Role of novel PKC isozymes. Am J Physiol Gatrointest Liver Physiol 284 (2003) G703
14. Han X., Fink M.P., and Delude R.L. Proinflammatory cytokines cause NO-dependent and independent changes in expression and localization of tight junction proteins in intestinal epithelial cell. Shock 19 (1994) 229
15. Colegio O.R., Van Itallie C.M., McCrea H.J., et al. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am J Physiol Cell Physiol 283 (2002) C142
16. Furuse M., Furuse K., Sasaki H., et al. Conversion of zonae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Bio 153 (2001) 263-272
17. Van Itallie C., Rahner C., and Anderson J. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 107 (2001) 1319
18. Noguchi M., Hiwathashi N., Liu Z., et al. Enhanced interferon-gamma production and B7-2 expression in isolated intestinal mononuclear cells from patients with Crohn's disease. J Gastroenterol 30 Suppl 8 (1995) S52
19. Fuss I.J., Neurath M., Boirivant M., et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFNγ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157 (1996) 1261
20. Inoue S., Matsumoto T., Iida M., et al. Characterization of cytokine expression in the rectal mucosa of ulcerative colitis: Correlation with disease activity. Am J Gastroenterol 94 (1999) 2441
21. Poritz L.S., Garver K.I., Thompson J., et al. Induction of claudin- 1 in IEC-6 cells by IL-4. J Sur Res 121 (2004) 311
22. Van Itallie C., Fanning A., and Anderson J. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am J Physiol Renal Physiol 28 (2003) F1078
23. Amasheh S., Meiri N., Gitter A., et al. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci 115 (2002) 4969
24. Adams R., Planchon S., and Roche K. IFNγ modulation of epithelial barrier function, time course, reversibility, and site of cytokine binding. J Immunol 150 (1993) 2356
25. Madara J.L., and Stafford J. Interferon-γ directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83 (1989) 724
26. Willemsen L.E.M., Hoetjes J.P., Van Deventer S.J.H., et al. Abrogation of IFN-γ mediated epithelial barrier disruption by serine protease inhibition. Clin Exp Immunol 142 (2005) 275
27. Bamias G., Nyce M.R., De La Rue S.A., et al. New concepts in the pathophysiology of inflammatory bowel disease. Ann Intern Med 143 (2005) 895
28. Schultz M., Scholmerich J., and Rath H.C. Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases. Dig Dis 21 (2003) 105
29. Macfarlane G.T., Furrie E., and Macfarlane S. Bacterial milieu and mucosal bacteria in ulcerative colitis. Novartis Found Symp 263 (2004) 57
30. Mahida Y.R., and Rolfe V.E. Host bacterial interactions in inflammatory bowel disease. Clin Sci 107 (2004) 331
31. Linskens R.K., Huijsdens X.W., Savelkoul P.H., et al. The bacterial flora in inflammatory bowel disease: Current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol 234 Suppl (2001) S29
32. Caradonna L., Amati L., Magrone T., et al. Enteric bacteria, lipopolysaccharides, and related cytokines in inflammatory bowel disease: Biological and clinical significance. J Endotoxin Res 6 (2000) 205
33. Nelms K., Keegan A.S., Zamorano J., et al. The IL-4 receptor: Signaling mechanisms and biologic functions. Ann Rev Immunol 17 (1999) 701
34. Dickensheets H.L., Venkataraman C., Schindler U., et al. Interferons inhibit activation of STAT6 by interleukin-4 in human monocytes by inducing SOCS-1 gene expression. Proc Natl Acad Sci USA 96 (1999) 10800
35. Kobayashi J., Inai T., Morita K., et al. Reciprocal regulation of permeability through a cultured keratinocyte sheet by IFN-γ and IL-4. Cytokine 28 (2004) 186
36. Hollander D., Vadheim C.M., Brettholz E., et al. Increased intestinal permeability in patients with Crohn's disease and their relatives: A possible etiologic factor. Ann Intern Med 105 (1986) 883
37. Niesser M., and Volk B.A. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 101 (1995) 428
38. Desreumaux P., Brandt E., Gambiez L., et al. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 113 (1997) 118